| NCT00392327 | Children´s Oncology Group|National Cancer Institute (NCI) | Anaplastic Medulloblastoma|Medulloblastoma | 2007-05-23 | PHASE3 |
| NCT04864717 | Lady Davis Institute | Acneiform Eruptions|Cancer, Treatment-Related | 2021-09-01 | PHASE4 |
| NCT01560585 | University Hospitals Cleveland Medical Center | Alzheimer´s Disease | 2012-04 | PHASE1|PHASE2 |
| NCT00701740 | Federal University of S?o Paulo | Photoaging|Epidermal p53 Expression | 2007-07 | PHASE2 |
| NCT04204304 | Ankara Training and Research Hospital | Musculoskeletal Disease Other|Isotretinoin Adverse Reaction|Vitamin D Deficiency | 2019-03-15 | NA |
| NCT00000764 | National Institute of Allergy and Infectious Diseases (NIAID)|Hoffmann-La Roche | HIV Infections|Anus Neoplasms | | PHASE1 |
| NCT06485505 | Zagazig University | Onychomycosis | 2024-07-12 | PHASE1 |
| NCT07142070 | Medipol University | Periodontal Diseases|Inflammation | 2025-09-01 | NA |
| NCT00003405 | Rush University Medical Center|National Cancer Institute (NCI) | Leukemia | 1998-04 | PHASE2 |
| NCT03471455 | Post Graduate Institute of Medical Education and Research, Chandigarh | Tinea | 2018-04 | PHASE2 |
| NCT05529888 | Aswan University | Acne Vulgaris | 2020-12-15 | PHASE4 |
| NCT03126916 | Children´s Oncology Group|National Cancer Institute (NCI) | Ganglioneuroblastoma|Ganglioneuroblastoma, Nodular|Neuroblastoma | 2018-05-14 | PHASE3 |
| NCT00003564 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors | | PHASE3 |
| NCT06242288 | Mostafa Bahaa | Acne Vulgaris | 2024-01-30 | PHASE3 |
| NCT00098020 | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Collapsing Glomerulopathy|Glomerulosclerosis, Focal Segmental | 2004-11-26 | PHASE2 |
| NCT01701479 | St. Anna Kinderkrebsforschung|University Medicine Greifswald|St. Anna Children´s Hospital, Vienna|Hospital Universitario La Fe|Istituto Giannina Gaslini|Gustave Roussy, Cancer Campus, Grand Paris|Schneider Children´s Medical Center, Israel|Great Ormond Street Hospital for Children NHS Foundation Trust|University Hospital, Toulouse|Johann Wolfgang Goethe University Hospital|Jena University Hospital|Children´s University Hospital, Ireland|University Hospital Tuebingen|Fondazione IRCCS Istituto Nazionale dei Tumori, Milano|Alder Hey Children´s NHS Foundation Trust|University Hospitals Bristol and Weston NHS Foundation Trust|Newcastle-upon-Tyne Hospitals NHS Trust|The Leeds Teaching Hospitals NHS Trust|NHS Greater Glasgow and Clyde|Medical University of Graz|Medical University Innsbruck|Centre Leon Berard|Hospital Infantil Universitario Ni?o Jesús, Madrid, Spain|University Hospital Southampton NHS Foundation Trust|Institut Curie|Fondazione IRCCS Ca´ Granda, Ospedale Maggiore Policlinico | Neuroblastoma | 2012-01 | PHASE1|PHASE2 |
| NCT05869188 | South Valley University | Acne Vulgaris | 2023-06-01 | NA |
| NCT04870489 | Tel-Aviv Sourasky Medical Center | Acne Vulgaris | 2017-11-01 | PHASE2 |
| NCT00176527 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI) | Prostate Cancer | 2002-11 | PHASE2 |
| NCT00005576 | National Cancer Institute (NCI) | Disseminated Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma | 2001-01 | PHASE1 |
| NCT02795143 | Massachusetts General Hospital | Toxic Epidermal Necrolysis | 2016-11 | NA |
| NCT00867178 | National Cancer Institute (NCI) | Medulloblastoma|Pineoblastoma|Supratentorial Embryonal Tumor, Not Otherwise Specified | 2009-02-25 | PHASE1 |
| NCT00005847 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Prostate Cancer | 2001-04-05 | PHASE2 |
| NCT01592045 | United Therapeutics | Neuroblastoma | 2012-08 | PHASE1|PHASE2 |
| NCT01888224 | Dr. Reddy´s Laboratories Limited | Healthy | 2011-06 | PHASE1 |
| NCT00098891 | National Cancer Institute (NCI) | Adult Grade III Lymphomatoid Granulomatosis|Anaplastic Large Cell Lymphoma|Angioimmunoblastic T-cell Lymphoma|Extranodal Marginal Zone B-cell Lymphoma of Mucosa-associated Lymphoid Tissue|Intraocular Lymphoma|Nodal Marginal Zone B-cell Lymphoma|Primary Central Nervous System Non-Hodgkin Lymphoma|Recurrent Adult Burkitt Lymphoma|Recurrent Adult Diffuse Large Cell Lymphoma|Recurrent Adult Diffuse Mixed Cell Lymphoma|Recurrent Adult Diffuse Small Cleaved Cell Lymphoma|Recurrent Adult Grade III Lymphomatoid Granulomatosis|Recurrent Adult Hodgkin Lymphoma|Recurrent Adult Immunoblastic Large Cell Lymphoma|Recurrent Adult Lymphoblastic Lymphoma|Recurrent Adult T-cell Leukemia+Lymphoma|Recurrent Cutaneous T-cell Non-Hodgkin Lymphoma|Recurrent Grade 1 Follicular Lymphoma|Recurrent Grade 2 Follicular Lymphoma|Recurrent Grade 3 Follicular Lymphoma|Recurrent Mantle Cell Lymphoma|Recurrent Marginal Zone Lymphoma|Recurrent Mycosis Fungoides+Sezary Syndrome|Recurrent Small Lymphocytic Lymphoma|Small Intestine Lymphoma|Splenic Marginal Zone Lymphoma|Stage IV Adult Burkitt Lymphoma|Stage IV Adult Diffuse Large Cell Lymphoma|Stage IV Adult Diffuse Mixed Cell Lymphoma|Stage IV Adult Diffuse Small Cleaved Cell Lymphoma|Stage IV Adult Hodgkin Lymphoma|Stage IV Adult Immunoblastic Large Cell Lymphoma|Stage IV Adult Lymphoblastic Lymphoma|Stage IV Adult T-cell Leukemia+Lymphoma|Stage IV Cutaneous T-cell Non-Hodgkin Lymphoma|Stage IV Grade 1 Follicular Lymphoma|Stage IV Grade 2 Follicular Lymphoma|Stage IV Grade 3 Follicular Lymphoma|Stage IV Mantle Cell Lymphoma|Stage IV Marginal Zone Lymphoma|Stage IV Mycosis Fungoides+Sezary Syndrome|Stage IV Small Lymphocytic Lymphoma|Unspecified Adult Solid Tumor, Protocol Specific|Waldenstr?m Macroglobulinemia | 2004-10 | PHASE1 |
| NCT06172296 | National Cancer Institute (NCI) | Ganglioneuroblastoma, Nodular|Neuroblastoma | 2024-04-19 | PHASE3 |
| NCT04389580 | Kafrelsheikh University | COVID-19 | 2021-09 | PHASE2 |
| NCT00567567 | Children´s Oncology Group|National Cancer Institute (NCI) | Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma | 2007-11-05 | PHASE3 |
| NCT00026312 | National Cancer Institute (NCI) | Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma | 2001-10-26 | PHASE3 |
| NCT04594759 | Medical University of South Carolina | Acne Vulgaris | 2020-11-11 | PHASE1|PHASE2 |
| NCT00003619 | Drexel University College of Medicine | Chronic Myeloproliferative Disorders|Leukemia|Myelodysplastic Syndromes|Thrombocytopenia | 1998-02 | PHASE1|PHASE2 |
| NCT06451237 | Alexandria University | Acne Vulgaris | 2018-01-20 | PHASE3 |
| NCT00040872 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Neuroblastoma | 2000-06 | PHASE2 |
| NCT06483971 | Superior University | Cornea | 2023-11-01 | NA |
| NCT02855138 | Kayseri Education and Research Hospital|Kayseri Erciyes University Faculty of Medicine | Adverse Effects of Medical Drugs | 2015-01 | PHASE4 |
| NCT00089258 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Neuroblastoma | 2004-07 | PHASE2 |
| NCT01103375 | Wake Forest University Health Sciences|National Cancer Institute (NCI) | Adult Anaplastic Astrocytoma|Adult Anaplastic Oligodendroglioma|Adult Diffuse Astrocytoma|Adult Giant Cell Glioblastoma|Adult Glioblastoma|Adult Gliosarcoma|Adult Mixed Glioma|Adult Oligodendroglioma|Recurrent Adult Brain Tumor | 2010-05 | PHASE1 |
| NCT03076021 | University of Washington|National Institute of General Medical Sciences (NIGMS) | CYP2D6 Polymorphism | 2016-07-26 | PHASE4 |
| NCT07054398 | Aswan University | Acne Vulgaris | 2025-01-10 | NA |
| NCT01861626 | Pierre Fabre Dermatology | Healthy Volunteers | 2013-05 | PHASE1 |
| NCT00975143 | Cipher Pharmaceuticals Inc. | Severe Nodular Acne | 2009-09 | PHASE3 |
| NCT02278861 | Universidade Federal de Goias|Conselho Nacional de Desenvolvimento Científico e Tecnológico|Theraskin|Germed Pharma | Actinic Keratosis | 2011-11 | PHASE2 |
| NCT00021359 | Fox Chase Cancer Center|National Cancer Institute (NCI) | Multiple Myeloma and Plasma Cell Neoplasm | 1999-08 | PHASE2 |
| NCT00526318 | German Society for Pediatric Oncology and Hematology GPOH gGmbH | Neuroblastoma | 2007-01 | NA |
| NCT00038376 | M.D. Anderson Cancer Center | Lymphoma, T-Cell|Mycosis Fungoides|Hematologic Neoplasms | 1990-05-08 | PHASE2 |
| NCT01474590 | Galderma R&D | Acne | 2011-11 | PHASE3 |
| NCT06698263 | University Hospital, Strasbourg, France | Men with Infertility | 2025-03-01 | PHASE4 |
| NCT01445028 | Wills Eye | Proliferative Vitreoretinopathy | 2011-09 | PHASE4 |
| NCT01888328 | Dr. Reddy´s Laboratories Limited | Healthy | 2001-05 | PHASE1 |
| NCT06179056 | Zagazig University | Acne Vulgaris | 2023-03-01 | |
| NCT00014729 | University of North Carolina | Epidermolysis Bullosa | 2000-10 | PHASE1 |
| NCT06201624 | Zagazig University | Melasma | 2023-03-01 | PHASE1 |
| NCT00002737 | European Organisation for Research and Treatment of Cancer - EORTC | Kidney Cancer | 1996-03 | PHASE3 |
| NCT03514771 | David Smart | Acne Scars - Mixed Atrophic and Hypertrophic | 2016-01-28 | NA |
| NCT01526603 | Masonic Cancer Center, University of Minnesota | Neuroblastoma | 2012-03-28 | NA |
| NCT01857934 | St. Jude Children´s Research Hospital|Cookies for Kids´ Cancer|CURE Childhood Cancer, Inc. | Neuroblastoma | 2013-07-05 | PHASE2 |
| NCT04290572 | Centro Dermatológico Dr. Ladislao de la Pascua | Flat Wart | 2020-03-15 | PHASE3 |
| NCT06378983 | Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | Moderate to Severe Acne Vulgaris | 2022-09-01 | NA |
| NCT05218486 | Alshimaa Abbas Mohamed Ebrahim | Acne Vulgaris | 2021-08-01 | PHASE4 |
| NCT00555399 | M.D. Anderson Cancer Center|Merck Sharp & Dohme LLC | Glioblastoma Multiforme|Anaplastic Glioma | 2007-11-28 | PHASE1|PHASE2 |
| NCT01319838 | Emory University|Children´s Healthcare of Atlanta | Neuroblastoma | 2011-03 | PHASE1 |
| NCT05903716 | Marmara University | Acne Vulgaris | 2022-09-15 | |
| NCT04361422 | Tanta University | COVID-19 | 2020-12-01 | PHASE3 |
| NCT06942039 | C17 Council | CNS Embryonal Tumor|CNS, Medulloblastoma|Atypical Teratoid Rhabdoid Tumor|Medulloblastoma, Childhood|Medulloblastoma, Group 3|Medulloblastoma, Group 4|Pineoblastoma|Neuroblastoma|Embryonal Tumor With Multilayered Rosettes|Embryonal Tumor With Abundant Neuropil and True Rosettes|Ependymoblastoma|Medulloepithelioma|CNS Embryonal Tumor With Rhabdoid Features|CNS Embryonal Tumor, Nos | 2025-09-23 | EARLY_PHASE1 |
| NCT00025012 | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) | Melanoma (Skin)|Non-melanomatous Skin Cancer | 1991-06 | NA |
| NCT06447480 | Centre Hospitalier Universitaire de Nice | Acne Vulgaris | 2025-07-01 | PHASE3 |
| NCT03033303 | Memorial Sloan Kettering Cancer Center|Y-mAbs Therapeutics | Neuroblastoma | 2017-01-23 | PHASE2 |
| NCT00882531 | Laboratoires Bailleul-Biorga|Quanta Medical | Papular-pustular Rosacea | 2007-02 | PHASE3 |
| NCT00004188 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 2001-02 | PHASE3 |
| NCT03786783 | National Cancer Institute (NCI) | Ganglioneuroblastoma|High Risk Neuroblastoma | 2019-03-04 | PHASE2 |
| NCT00499616 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 2007-10-08 | PHASE3 |
| NCT07309341 | U?ak University|The Scientific and Technological Research Council of Turkey | Smell Dysfunction | 2025-06-01 | NA |
| NCT01334515 | Children´s Oncology Group|National Cancer Institute (NCI) | Recurrent Neuroblastoma | 2011-09 | PHASE2 |
| NCT00217412 | National Cancer Institute (NCI) | Childhood Acute Promyelocytic Leukemia (M3)|Childhood Atypical Teratoid+Rhabdoid Tumor|Childhood Burkitt Lymphoma|Childhood Chronic Myelogenous Leukemia|Childhood Diffuse Large Cell Lymphoma|Childhood Immunoblastic Large Cell Lymphoma|Juvenile Myelomonocytic Leukemia|Recurrent Childhood Acute Lymphoblastic Leukemia|Recurrent Childhood Acute Myeloid Leukemia|Recurrent Childhood Grade III Lymphomatoid Granulomatosis|Recurrent Childhood Large Cell Lymphoma|Recurrent Childhood Lymphoblastic Lymphoma|Recurrent Childhood Medulloblastoma|Recurrent Childhood Small Noncleaved Cell Lymphoma|Recurrent Childhood Supratentorial Primitive Neuroectodermal Tumor|Recurrent Neuroblastoma|Recurrent+Refractory Childhood Hodgkin Lymphoma|Relapsing Chronic Myelogenous Leukemia|Unspecified Childhood Solid Tumor, Protocol Specific | 2005-08 | PHASE1 |
| NCT01020539 | Columbia University | Acute Myelogenous Leukemia|Myelodysplastic Syndrome|Juvenile Myelomonocytic Leukemia | 2002-09-11 | PHASE1 |
| NCT01139749 | Federal University of S?o Paulo | Seborrhea|Seborrheic Dermatitis|Quality of Life | 2011-10 | PHASE4 |
| NCT04167982 | Shanghai Dermatology Hospital|Huadong Hospital|RenJi Hospital | Acne | 2020-03-28 | NA |
| NCT00001073 | National Institute of Allergy and Infectious Diseases (NIAID) | HIV Infections|Cervix, Dysplasia | | PHASE3 |
| NCT04154293 | Timber Pharmaceuticals Inc. | Congenital Ichthyosis | 2019-12-03 | PHASE2 |
| NCT00004110 | Memorial Sloan Kettering Cancer Center|National Cancer Institute (NCI) | Neuroblastoma | 1999-08 | PHASE2 |
| NCT02457520 | Sun Pharmaceutical Industries Limited | Acne | 2015-01-21 | PHASE4 |
| NCT00017368 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 2001-04 | PHASE2 |
| NCT07481370 | University of Nebraska | Oligospermia|Azoospermia, Nonobstructive|Infertility | 2026-04-13 | PHASE2 |
| NCT02180425 | University of California, Davis | Acne | 2013-11 | |
| NCT02771743 | Samsung Medical Center | Newly Diagnosed High Risk Neuroblastoma | 2015-04 | PHASE2 |
| NCT04385277 | Children´s Oncology Group|National Cancer Institute (NCI) | Ganglioneuroblastoma, Nodular|Neuroblastoma | 2020-12-31 | PHASE2 |
| NCT00334789 | National Cancer Institute (NCI) | Adult Solid Neoplasm | 2006-06-12 | PHASE1 |
| NCT00070200 | Children´s Oncology Group|National Cancer Institute (NCI) | Neuroblastoma | 2004-03 | PHASE1 |
| NCT04940767 | Edward Lain, MD|Vyne Therapeutics Inc. | Acne Vulgaris | 2021-06-28 | PHASE4 |
| NCT00842907 | Federal University of S?o Paulo | Photodamage|Photoaging | 2009-05 | PHASE2 |
| NCT06225570 | Medical University of South Carolina | Acne Vulgaris | 2025-02-01 | EARLY_PHASE1 |
| NCT05316675 | Assiut University | Acne Vulgaris | 2022-12 | PHASE4 |
| NCT01888341 | Dr. Reddy´s Laboratories Limited | Healthy | 2002-08 | PHASE1 |
| NCT00112502 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Brain and Central Nervous System Tumors|Glioblastoma Multiforme | 2005-09 | PHASE2 |
| NCT07012811 | Tishreen University | Plane Warts | 2024-02-12 | PHASE4 |
| NCT01041638 | National Cancer Institute (NCI) | High Risk Neuroblastoma | 2009-12-21 | PHASE3 |
| NCT01969058 | Advancing Clinical Therapeutics Globally for HIV+AIDS and Other Infections|National Institute of Allergy and Infectious Diseases (NIAID) | HIV-1 Infection | 2014-07-02 | PHASE2 |
| NCT00025038 | National Cancer Institute (NCI) | Juvenile Myelomonocytic Leukemia | 2001-06 | PHASE2 |
| NCT00002506 | Hoag Memorial Hospital Presbyterian|Cancer Biotherapy Research Group | Cervical Cancer|Esophageal Cancer|Head and Neck Cancer|Lung Cancer|Non-melanomatous Skin Cancer|Penile Cancer | 1992-08 | PHASE2 |
| NCT00939965 | Children´s Cancer and Leukaemia Group | Neuroblastoma | 2009-02 | NA |
| NCT01711554 | National Cancer Institute (NCI) | Recurrent Neuroblastoma|Refractory Neuroblastoma | 2013-02-04 | PHASE1 |
| NCT02620813 | University of California, Davis | Acne Vulgaris | 2015-10 | EARLY_PHASE1 |
| NCT01208454 | National Cancer Institute (NCI) | Localized Unresectable Neuroblastoma|Recurrent Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma | 2010-12 | PHASE1 |
| NCT01175356 | Children´s Oncology Group|National Cancer Institute (NCI) | Ganglioneuroblastoma|Localized Resectable Neuroblastoma|Localized Unresectable Neuroblastoma|Regional Neuroblastoma|Stage 4 Neuroblastoma|Stage 4S Neuroblastoma | 2011-12-21 | PHASE1 |
| NCT07420894 | Multan Medical And Dental College | Dermatophytosis|Trichophyton Infection|Resistant Dermatophyte Infection | 2025-01-29 | NA |
| NCT05666765 | Tanta University | Acne Vulgaris | 2023-01-01 | PHASE4 |
| NCT05684861 | South Valley University | Acne Vulgaris | 2022-01-01 | PHASE2 |
| NCT00324740 | National Cancer Institute (NCI) | Recurrent Renal Cell Cancer|Stage III Renal Cell Cancer|Stage IV Renal Cell Cancer | 2006-03 | PHASE1|PHASE2 |
| NCT04660916 | Sinan ?z?elik | Isotretinoin|Nail Abnormality | 2019-10-22 | |
| NCT00138151 | University of Medicine and Dentistry of New Jersey|National Cancer Institute (NCI) | Cervical Cancer | 2001-03 | PHASE2 |
| NCT07228481 | Premier Specialists, Australia|Roche Products Limited | Acne Cystic | 2001-06-26 | PHASE4 |
| NCT01863615 | GlaxoSmithKline | Skin Infections (Acne) | 2011-08-26 | PHASE1 |
| NCT00003599 | M.D. Anderson Cancer Center|National Cancer Institute (NCI) | Lung Cancer | | PHASE3 |
| NCT01404130 | University of Aberdeen | Acne Vulgaris | 2008-09 | PHASE4 |
| NCT00030719 | University of Leicester | Neuroblastoma | 2001-12 | PHASE3 |
| NCT00003585 | University of New Mexico|National Cancer Institute (NCI) | Kidney Cancer | 1996-08 | PHASE1|PHASE2 |
| NCT04909515 | Y-mAbs Therapeutics | Neuroblastoma | 2021-12-02 | PHASE2 |
| NCT00054561 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Head and Neck Cancer | 2003-11-26 | PHASE3 |
| NCT04156815 | xjpfW | Acne Vulgaris | 2018-07-05 | NA |
| NCT00416585 | Shahid Beheshti University of Medical Sciences | Acne | 2005-10 | PHASE1 |
| NCT05413200 | Istanbul Training and Research Hospital | Acne Vulgaris|Isotretinoin|Atrophic Acne Scar | 2021-11-01 | |
| NCT01888289 | Dr. Reddy´s Laboratories Limited | Healthy | 2001-07 | PHASE1 |
| NCT02498288 | GlaxoSmithKline | Acne Vulgaris | 2013-05-31 | PHASE1 |
| NCT00078988 | Children´s Oncology Group|National Cancer Institute (NCI) | Brain Tumor|Central Nervous System Tumor | 2004-10 | PHASE3 |
| NCT01183429 | Memorial Sloan Kettering Cancer Center | Neuroblastoma | 2010-08-12 | PHASE2 |
| NCT00062010 | Eastern Cooperative Oncology Group|National Cancer Institute (NCI) | Lung Cancer | 2004-05-26 | PHASE2 |
| NCT00969722 | United Therapeutics | Primary Refractory Neuroblastoma | 2009-08 | PHASE2 |
| NCT01183884 | Memorial Sloan Kettering Cancer Center | Neuroblastoma | 2010-08 | PHASE2 |
| NCT00808899 | St. Jude Children´s Research Hospital | Neuroblastoma | 2008-12 | PHASE2 |
| NCT05373901 | BeiGene | High-risk Neuroblastoma | 2022-06-07 | PHASE1 |
| NCT03611595 | Peter Zage|Exelixis | Solid Tumor | 2018-08-28 | PHASE1 |
| NCT01183416 | Memorial Sloan Kettering Cancer Center | Neuroblastoma | 2010-08 | PHASE2 |
| NCT00528437 | NYU Langone Health|Children´s Hospitals and Clinics of Minnesota|Schneider Children´s Hospital | Brain Tumors | 2005-10 | PHASE2 |